THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net
S U M M A R Y
DIARY: October 7, 2007 06:03 AM Sunday;
Rod Welch
Letter to UCSF change CT test to 12 weeks, HER2 retest status increase chemo drugs.
1...Summary/Objective
2...CT Test Frequency Change from 8 to 12 Weeks Clinical Trial Cetuximab
3...Status Change HER2 Increase Treatments with Change in Standards
..............
Click here to comment!
CONTACTS
SUBJECTS
Default Null Subject Account for Blank Record
0403 -
0403 - ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS 2 5E5J.
040502 -
040503 -
040504 -
040505 -
040507 - ..
0406 -
0407 -
0408 - Progress
0409 -
040901 - CT Test Frequency Change from 8 to 12 Weeks Clinical Trial Cetuximab
040902 -
040903 -
040904 - Millie sent a letter to Doctor Rugo at UCSF saying...
040905 -
040906 - 1. Subject: Sore Subject CT Tests Reduce from 8 Weeks to 12 Weeks
040907 - Date: Sun, 07 Oct 2007 06:09:32 -0700
040914 - ..
040915 - 2. Dear Doctor Rugo,
040917 - ..
040918 - 3. Brigid mentioned during examination on 070920 that you might be
040919 - able to get approval for changing CT tests from 8 to 12 week
040920 - intervals, more a quarterly schedule. ref SDS 2 5E5J This
040921 - would reduce costs, and also reduce wear and tear on my sore
040922 - arm. Catherine, my nurse in the Infusion Clinic, noticed this
040923 - past Thursday on 071004 that my arm had still not recovered
040924 - from difficulty (swelled, black and blue), ref SDS 4 DE62,
040925 - finding a vein by the technician at Kaiser for the CT test on
040926 - Sunday, 070930. ref SDS 3 615J
040927 -
040928 - [On 071009 UCSF got approval from clinical trial sponsors
040929 - to change frequency of CT tests from 8 to 12 weeks.
040930 - ref SDS 6 I48R
040932 - ..
040933 - 4. Catherine explained more testing makes this "sore subject"
040934 - worse because there is barely enough time to recover between
040935 - tests 8 weeks apart. She explained some tricks the infusion
040936 - nurses use to minimize problems. CT test technicians are
040937 - careful and considerate at Kaiser, but they do not have the
040938 - skill to avoid problems. This past test took 3 or 4 needle
040939 - pricks to finally make the infusion for the test. Catherine
040940 - also indicated that the port cannot be used for this procedure,
040941 - so we are stuck with trying to use my one arm that is wearing
040942 - out.
040944 - ..
040945 - 5. Fortunately, CT tests for several years all seem to show NED,
040946 - so possibly there is justification to reduce the frequency of
040947 - testing.
040948 -
040949 -
040950 -
0410 -
SUBJECTS
Default Null Subject Account for Blank Record
0503 -
050401 - ..
050402 - Status Change HER2 Increase Treatments with Change in Standards
050403 -
050404 -
050405 - 6. I attended a support group event last weekend. An oncology
050406 - doctor with Diablo Valley Medical Group advised there has been
050407 - some change in standards assessing HER2 negative, which opens
050408 - the door for some patients to expand treatments (Herceptin??).
050409 - The doctor seemed to say that 2.0 has been the cut off, but
050410 - this has been relaxed to 1.6? I was originally tested on
050411 - 020304, and Doctor Johnson reported results as simply
050412 - "negative" during a meeting at Kaiser on 020321. ref SDS 1 6Q6J
050413 -
050414 - [On 081120 pathology reports Millie still triple negative
050415 - on biopsy performed 081107 to test for status change,
050416 - ref SDS 15 HR4F; however, the pathology does not present
050417 - actual findings to support the conclusion, and further the
050418 - criteria presented for evaluating HER2neu does not seem to
050419 - correlate well with research today. ref SDS 15 LF4R
050421 - ..
050422 - [On 081202 1456 Kaiser submitted results of pathology for
050423 - biopsy on 081107 showing HER2 neu FISH test = 1.1,
050424 - ref SDS 17 FG5G, well below criteria for positive 2.0, and
050425 - below change in criteria to 1.6 reported under
050426 - consideration on 071007. ref SDS 5 S68T
050428 - ..
050429 - 7. There was supposedly a retest for status change using a biopsy
050430 - 2 years later on 040419 that also diagnosed IBC. Doctor
050431 - Johnson reported on 060711 that biopsy on 040419 found no
050432 - change in status, but again diagnostic numbers have not been
050433 - reviewed. Is it worthwhile to check the actual numbers, or
050434 - possibly to do another biopsy, or am I just whistling Dixie??
050435 -
050436 - [On 071009 UCSF fails to respond; follow up inquiry
050437 - submitted. ref SDS 6 I44U
050439 - ..
050440 - [On 071009 Doctor Rugo advises that UCSF continue to rely
050441 - on HER2 negative standard at 2, i.e., there has been not
050442 - change in criteria. ref SDS 6 HH4W
050444 - ..
050445 - [On 080207 the Doctor asks investigating status change to
050446 - assess options for treating Millie's relapse. ref SDS 7
050447 - 6S6G; requests report on biopsy 040419. ref SDS 7 655G
050449 - ..
050450 - [On 080219 UCSF receives report for biopsy on 040419 and
050451 - determines there is no change in Millie's triple negative
050452 - status, which would increase treatment options. ref SDS 8
050453 - VX6G
050455 - ..
050456 - [On 081016 letter to medical team confirms Doctor Rugo's
050457 - request for Kaiser to biopsy of lymph node in left
050458 - supraclavicular, and orders evaluation of triple negative
050459 - to investigate expanding options to treat Millie's 5th
050460 - relapse of IBC. ref SDS 9 J36R
050462 - ..
050463 - [On 081022 FNA biopsy performed at Kaiser to evaluate
050464 - triple negative status. ref SDS 10 NZ5N
050466 - ..
050467 - [On 081023 FNA biopsy positive for breast cancer,
050468 - ref SDS 11 4Q9Q; need to do core biopsy because lab says
050469 - FNA biopsy does not produce enough material to check for
050470 - status change. ref SDS 11 4Q5V
050472 - ..
050473 - [On 081119 Kaiser submits summary of final pathology
050474 - report, ref SDS 13 5O8G, for the biopsy on 081107,
050475 - ref SDS 12 496L, and it shows status is unchanged, still
050476 - triple negative. ref SDS 13 UQ5P
050478 - ..
050479 - [On 081119 Millie asks Kaiser for pathology report on
050480 - biopsy performed 081107 and reporting triple negative
050481 - status unchanged; need to evaluate criteria in relation to
050482 - notice today that criteria for HER2neu has changed.
050483 - ref SDS 14 L34X
050485 - ..
050486 - [On 081120 Millie receives complete pathology report for
050487 - biopsy on 081107, ref SDS 15 1E6K; presents criteria for
050488 - determining status, ref SDS 15 LF9R, but does not present
050489 - findings that support a conclusion of triple negative.
050490 - ref SDS 15 QQ3K
050492 - ..
050493 - [On 081202 1038 Millie's letter to Kaiser, ref SDS 16 UV5I,
050494 - asks Doctor Daamen for findings in pathology report for
050495 - biopsy on 081107 that support conclusion of triple
050496 - negative. ref SDS 16 GZ4P
050498 - ..
050499 - [On 081202 1456 Kaiser submitted results of pathology for
050500 - biopsy on 081107 showing HER2 neu FISH test = 1.1,
050501 - ref SDS 17 FG5G, well below criteria for positive 2.0, and
050502 - below change in criteria to 1.6 reported under
050503 - consideration on 071007. ref SDS 0 S68T
050504 -
050505 -
050506 -
050516 -
050517 -
050518 -
050519 -
050520 -
050521 -
050522 -
050523 -
050524 -
050525 -
050526 -
050527 -
050528 -
050529 -
050530 -
050531 -
050532 -
050533 -
050534 -
0506 -